| "Value of FDA Compliant Global Drug Development Plan" TiE. The product life cycle for life science enterprises costs in investments 900 million and it takes 10 to14 years before one makes a market launch. The regulatory landscape is increasingly global. Last year FDA approved only 3 new drugs when 10 year ago about 12 drugs were approved. The cost of drug development is increasing and number of innovative products are being approved is reducing. To add to this mix, Venture funds are available to only the very few favorable drug candidates. How do the corporations find a way to successfully comply with the FDA and at the same time the investors need? See http://www.socal.tie.org |
RSS